Pacemaker Mediated Tachycardia Detection Algorithm
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing algorithms for detecting pacemaker-mediated tachycardia (PMT) often lead to inappropriate interventions, such as extending the post-ventricular atrial refractory period (PVARP), which can result in dropped beats or interruption of cardiac resynchronization therapy (CRT) pacing, especially in patients with high intrinsic rates.
Innovation Solution
An implantable medical device is configured to confirm PMT through a confirmation phase involving periodic extensions of the sensed atrioventricular (SAV) interval and measurement of ventricular atrial (VA) intervals, with a processor implementing a measurement cycle that includes measuring Vp-As intervals before and after lengthening the SAV by 50ms, to determine if PMT is present by checking for unchanged VA intervals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing PMT detection algorithms are used, then PMT detection capability is provided, but inappropriate interventions occur leading to dropped beats or interruption of CRT pacing
Solution Approach 1:
The patent applies preliminary action by implementing a confirmation phase before executing PMT intervention. The device performs preliminary measurements of VA intervals at different SAV intervals to confirm PMT presence before extending PVARP. This preliminary verification prevents inappropriate interventions that could cause dropped beats or CRT pacing interruption.
Solution Approach 2:
The patent uses feedback by measuring VA intervals in response to SAV interval extensions and using this feedback to confirm whether PMT is truly present. The system adjusts SAV interval, observes the effect on VA interval, and uses this feedback loop to verify PMT detection before committing to intervention, thereby reducing false positives and inappropriate interventions.
2Reliability
If PVARP is extended to intervene in detected PMT, then PMT treatment is provided, but pacing therapy may be interrupted or dropped beats may occur
Solution Approach 1:
The system performs preliminary verification by measuring VA intervals at baseline and after SAV extension before executing PVARP extension. This preliminary action ensures that PMT intervention is only applied when truly indicated, maintaining pacing therapy continuity and preventing unnecessary interruptions.
Solution Approach 2:
The system uses feedback from VA interval measurements to determine whether PVARP extension should be applied. By continuously monitoring whether VA intervals remain unchanged after SAV extension, the system provides feedback that confirms true PMT presence before committing to therapy that could interrupt pacing.
3Measurement precision
If confirmation phase with SAV interval extensions is implemented, then PMT detection accuracy is improved, but device operation complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the detection process into distinct phases: initial PMT detection, confirmation phase with SAV extensions, and intervention phase. The confirmation phase itself is segmented into multiple measurement cycles (e.g., 6 additional beats) to verify PMT presence. This structured segmentation improves detection precision while making the complex algorithm more manageable and systematic.
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
A method of employing an implantable medical device to detect pacemaker mediated tachycardia (PMT) and adjusting a parameter (e.g. PVARP) in response to confirmation of the PMT. The method comprises, with a processor located in the implantable medical device, (1) measuring a first Vp-As (VA1), (2) lengthening SAV by 50ms for 1 beat in response to measuring VA1, (3) measuring a second Vp-As (VA2), (4) returning to a normal SAV, (5) measuring a third Vp-As (VA3), (6) determining whether VA1=VA2 and VA1=VA3, (7) in response to determining whether VA1=VA2 and VA1=VA3, confirming presence of PMT, and (8) in response to confirming presence of PMT, PVARP is extended.